Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
HLN

Haleon plc

HLNLSEUnited KingdomHealthcareDrug Manufacturers - Specialty & GenericFTSE 100

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth…more

P/E21.22xP/B2.07xROIC7.1%Dividend yield1.9%
£33.59B
Market Cap
EV: £41.36B
MOM3
QUAL8
VAL5
RSK2
HLN
£33.59B
Market Cap · EV £41.36B

Haleon plc

MOM3
QUAL8
VAL5
RSK2

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth…more

Latest RNS from Haleon plc

Analyst consensus: Hold

As of 10 Nov 2026, 18 analysts rate Haleon plc a Hold, with 50% buy ratings and a mean price target of 376p (range 290p–478p), +14% vs the current price.

Strong buy: 3Buy: 6Hold: 8Sell: 0Strong sell: 1

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 147p against a current price of 333p (-56%), based on EV/EBITDA.

More Healthcare companies